VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Phase II study of carboplatin and erlotinib (Tarceva, OSI-774) in patients with recurrent glioblastoma.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Phase II study of carboplatin and erlotinib (Tarceva, OSI-774) in patients with recurrent glioblastoma.
Phase II study of carboplatin and erlotinib (Tarceva, OSI-774) in patients with recurrent glioblastoma. J Neurooncol. 2008 Oct; 90(1):89-97.
View in:
PubMed
subject areas
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols
Biomarkers, Tumor
Brain Neoplasms
Carboplatin
Disease-Free Survival
ErbB Receptors
Erlotinib Hydrochloride
Female
Glioblastoma
Humans
Immunohistochemistry
Kaplan-Meier Estimate
Karnofsky Performance Status
Male
Middle Aged
Neoplasm Recurrence, Local
Proto-Oncogene Proteins c-akt
PTEN Phosphohydrolase
Quinazolines
authors with profiles
KENNETH R HESS
JOHN FREDERICK DE GROOT